Cogent Biosciences, Inc.COGTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank70
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P70
Within normal range
vs 5Y Ago
-2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-27.26%
2024-35.26%
2023-29.49%
2022-101.89%
2021-63.91%
202013.64%
2019-27.78%
2018-25.76%
2017-38.60%
2016-205.22%